Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) Stock Information | RedChip

Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP)


$17.6950
+0.9650 ( +5.64% ) 79.2K

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company'sĀ development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Market Data


Open


$17.6950

Previous close


$16.7300

Volume


79.2K

Market cap


$203.76M

Day range


$16.6100 - $17.7300

52 week range


$4.0000 - $61.9000

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 May 20, 2024
8-k 8K-related 16 May 20, 2024
8-k 8K-related 11 May 09, 2024
10-q Quarterly Reports 81 May 07, 2024
8-k 8K-related 12 May 07, 2024
4 Insider transactions 1 Apr 11, 2024
8-k 8K-related 13 Apr 10, 2024
ars Annual reports 1 Apr 02, 2024
def Proxies and info statements 16 Apr 02, 2024
pre Proxies and info statements 5 Mar 22, 2024

Latest News